Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.350
-0.340 (-20.12%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Lexaria Bioscience Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2015 - 2019
Market Capitalization
24628183531
Upgrade
Market Cap Growth
-37.67%627.66%-51.77%-50.18%13.53%-42.60%
Upgrade
Enterprise Value
17535102729
Upgrade
Last Close Price
1.353.911.052.966.2210.38
Upgrade
PS Ratio
40.90133.1537.5668.9748.9298.93
Upgrade
PB Ratio
3.328.073.172.312.7112.55
Upgrade
P/TBV Ratio
3.578.223.292.362.7413.95
Upgrade
EV/Sales Ratio
32.87114.3321.5839.4437.1992.55
Upgrade
Debt / Equity Ratio
0.020.020.060.010.010.06
Upgrade
Asset Turnover
0.070.080.040.020.090.11
Upgrade
Inventory Turnover
---2.112.390.81
Upgrade
Quick Ratio
3.776.105.9932.7978.907.20
Upgrade
Current Ratio
4.247.188.0435.9681.188.53
Upgrade
Return on Equity (ROE)
-145.55%-112.36%-130.18%-71.35%-73.16%-166.85%
Upgrade
Return on Assets (ROA)
-77.60%-59.56%-73.59%-39.21%-44.17%-94.23%
Upgrade
Return on Capital (ROIC)
-88.48%-66.91%-76.32%-39.70%-44.99%-101.11%
Upgrade
Earnings Yield
-39.58%-9.38%-78.45%-41.27%-11.39%-12.63%
Upgrade
FCF Yield
-31.43%-8.09%-69.63%-27.98%-11.28%-8.41%
Upgrade
Buyback Yield / Dilution
-84.74%-87.24%-12.38%-34.02%-58.34%-6.95%
Upgrade
Updated Jan 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q